identification using a scanning technique followed by DNA sequencing. In classic sporadic RTT, a mutation can be detected in 70%-90% of cases. However, in atypical RTT and/or familial cases, this rate drops to 34% and 29%-45%, respectively (13) (14) (15) . In Angelman-like patients, MECP2 mutations are seen in Յ10% of cases (4, 5, 16 ) . Thus, current protocols are not cost-efficient, except in very typical circumstances. We designed a simpler strategy suitable to screen for MECP2 mutations in girls, even at the expense of some sensitivity.
We accessed RettBase (17 ) and identified the 10 most common mutations associated with Rett syndrome: 502CϾT (R168X), 473CϾT (T158M), 763CϾT (R255X), 808CϾT (R270X), 880CϾT (R294X), 916CϾT (R306X), 397CϾT (R133C), 316CϾT (R106W), 419CϾT (A140V), and G269fs (806delG). We designed 4 primer pairs to amplify regions of exons 3 and 4, where these mutations occur (see Table 1 in the Data Supplement that accompanies the online version of this Letter at http://www. clinchem.org/content/vol52/issue3/). We then used our multiplex minisequencing technique (18 ) to identify those 10 mutations rapidly and inexpensively (see primers in Table 2 in the online Data Supplement). Three of the amplicons from exons 3 and 4 (primers Mecp 1 to -3) were amplified together in a triplex format, whereas the 3Ј end of exon 4 (primer Mecp 4) was amplified separately to detect microdeletions. After inspecting the amplification products in a gel, we purified them to eliminate the excess primers and deoxynucleoside triphosphates (18 ) and used them as templates for multiplex minisequencing.
To validate our procedure, we obtained from the Coriell Cell Repository (19 ) DNA samples from patients with 5 of the 10 MECP2 mutations: R168X, R255X, R294X, R306X, and R106W. The minisequencing results ( Fig. 1) were excellent, but there was some background in the region 45-58 bp (Fig. 1 ) that occasionally interfered with recognition of the R306C and R255X mutations. Because of this, we duplicated the multiplex minisequencing in 2 overlapping reactions: one encompassing all primers ( Fig. 1) and the other containing only the first 7 minisequencing primers (see the online Data Supplement). In all 5 Coriell samples, the MECP2 mutations were diagnosed correctly.
In addition to base changes, recurrent small deletions, especially in the region coding for the C-terminal domain, may lead to Rett syndrome. To detect these deletions, we amplified the Mecp 4 amplicon, which extended from nucleotides 1073 to 1396 in the cDNA, and evaluated the PCR products in 6% polyacrylamide gels. Our procedure readily identified the 26-bp deletion (1160del26) in sample NA16382 from the Coriell Cell Repository.
Schanen et al. Some girls clinically diagnosed as having an Angelman syndrome-like phenotype and who do not present any abnormalities in the 15q11-13 region or methylation defects in UBE3A have been shown to carry MECP2 mutations, generally the same ones seen in Rett syndrome (4, 5, 16, 20 ) . We used our minisequencing protocol to study 7 such patients from our clinical service. Among these, we detected 1 with the relatively common nonsense mutation 808CϾT. Although our sample size was small, it demonstrated the usefulness of our procedure.
After Down syndrome, the fragile X and Rett syndromes are believed to be the most common causes of developmental delay in females (21 ) . MECP2 mutations may be responsible for Ն2.5% of the institutionalized individuals with mental retardation (22 ) . The exact numbers are not known because molecular testing has been a costly and slow endeavor. We hope that the availability of our simple and inexpensive screening technique will facilitate the diagnosis of patients with MECP2 mutations.
